Mirosław Kowalski

Prof. Mirosław Kowalski


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KKKowalczyk Kowalczyk
Kowalczyk Kowalczyk
MKMirosław Kowalski
Mirosław Kowalski
Functionally single-ventricle (FSV) defects are complex congenital heart anomalies that require Fontan palliation, a surgical procedure redirecting systemic venous blood directly to the pulmonary arteries, bypassing the heart. Despite improvements in surgical techniques and perioperative care leading to enhanced survival rates, patients remain vulnerable to significant long-term complications, due to the unique Fontan circulation physiology. This circulation relies on low pulmonary vascular resistance and preserved single-ventricle function but predisposes patients to venous congestion and reduced cardiac output, resulting in multi-organ dysfunction. Key cardiovascular complications include systolic and diastolic dysfunction of the single ventricle, atrioventricular valve regurgitation, arrhythmias, pulmonary vascular disease, and thromboembolic events. Systemic complications encompass Fontan-associated liver disease (FALD), protein-losing enteropathy (PLE), plastic bronchitis (PB), renal impairment, and endocrine and psychosocial burdens. All the problems induce frequent hospitalizations, psychological challenges, and impaired educational and employment opportunities. Comprehensive management requires multidisciplinary approaches addressing the complex interplay of hemodynamic, organ-specific problems, and psychosocial factors inherent to Fontan physiology.

Verified
Journal Article
Open access
PDF file
Katarzyna WiktroskaKatarzyna Wiktroska
Katarzyna Wiktroska
OWOlgierd Woźniak
Olgierd Woźniak
PKPatryk Krzeminski
Patryk Krzeminski
KMKamila Maliszewska-Olejniczak
Kamila Maliszewska-Olejniczak
IWIrena Zofia Wadas
Irena Zofia Wadas
EBElżbieta Katarzyna Biernacka
Elżbieta Katarzyna Biernacka
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited myocardial disease characterized by desmosomal disruption, fibrofatty replacement, and ventricular arrhythmias. Although autoantibodies against desmoglein-2 (DSG2) are implicated in ARVC, their myocardial localization remains unproven. We investigated DSG2-reactive IgG in myocardial tissue from a patient with ARVC and compared the findings with non-failing donor myocardium. Immunofluorescence and confocal microscopy revealed reduced, discontinuous DSG2 expression and altered desmoplakin and plakoglobin distribution. IgG colocalized more extensively with DSG2 in ARVC than in control myocardium, consistent with elevated serum anti-DSG2 autoantibodies. These findings provide tissue-level evidence of the spatial co-occurrence of tissue-bound IgG and DSG2 in ARVC and support further investigation of autoimmune mechanisms in disease progression.

14 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JMJakub Malinowski
Jakub Malinowski
ŁNŁukasz Nowotka
Łukasz Nowotka
Jakub Kosma RokickiJakub Kosma Rokicki
Jakub Kosma Rokicki
OWOlgierd Woźniak
Olgierd Woźniak
PSPaweł Syska
Paweł Syska
MKMirosław Kowalski
Mirosław Kowalski
Background: Evidence to guide risk stratification after ICD implantation in adults with congenital heart disease (ACHD) is limited. We sought predictors of appropriate ICD intervention in this population. Methods: Consecutive ACHD patients implanted with an ICD (2009–2023) were analysed retrospectively. Time to first appropriate ICD intervention was modelled from a single, consistently defined start of observation. Because only 24 events were available, candidate predictors were pre-specified and each model limited to two covariates; sparse predictors used Firth penalisation, and multiplicity was addressed by the Benjamini–Hochberg false discovery rate procedure. Results: Among 56 patients (73.2% male; 22 primary and 34 secondary prevention), appropriate intervention occurred in 24 (42.9%) over a median follow-up of 51.9 months. Atrial fibrillation (HR 2.75, 95% CI 1.22–6.23) and radiographic cardiomegaly (HR 3.99, 95% CI 1.28–12.40) showed the largest unadjusted associations, whereas individual congenital lesions and disease-severity descriptors did not. No predictor remained significant after Benjamini–Hochberg correction (q ≈ 0.10). The very high hazard ratios for sparsely represented thyroid disorders (hypothyroidism, n = 2; hyperthyroidism, n = 4) were unstable under penalised estimation and are reported as exploratory. A pre-specified two-variable model (atrial fibrillation plus radiographic cardiomegaly) showed modest discrimination (optimism-corrected Harrell’s C-index 0.63). Conclusions: In a heterogeneous real-world ACHD cohort, a history of atrial fibrillation and radiographic cardiomegaly were associated with appropriate ICD intervention. Given the small number of events and the sparsity of several predictors, these findings should be regarded as hypothesis-generating and require validation in larger multicentre ACHD cohorts.